Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2012 1
2015 1
2016 1
2017 2
2018 2
2020 3
2021 3
2022 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.
Carretero G, Puig L, Carrascosa JM, Ferrándiz L, Ruiz-Villaverde R, de la Cueva P, Belinchon I, Vilarrasa E, Del Rio R, Sánchez-Carazo JL, López-Ferrer A, Peral F, Armesto S, Eiris N, Mitxelena J, Vilar-Alejo J, A Martin M, Soria C; from the Spanish Group of Psoriasis. Carretero G, et al. Among authors: vilar alejo j. J Dermatolog Treat. 2018 Jun;29(4):334-346. doi: 10.1080/09546634.2017.1395794. Epub 2017 Nov 21. J Dermatolog Treat. 2018. PMID: 29099667 Free article. Review.
Migratory, recurrent skin eruption in a returning traveller.
Grau-Pérez M, Vilar-Alejo J, de la Rosa-Del Rey MDP, Hernández-Febles M, Pérez-Arellano JL. Grau-Pérez M, et al. Among authors: vilar alejo j. Australas J Dermatol. 2018 Nov;59(4):e307-e308. doi: 10.1111/ajd.12851. Epub 2018 Jun 4. Australas J Dermatol. 2018. PMID: 29869372 No abstract available.
Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience.
Nieto Benito LM, Carretero G, Rivera-Díaz R, Carrascosa JM, Daudén E, de la Cueva P, Sahuquillo-Torralba A, Herrera-Acosta E, Baniandrés-Rodríguez O, Lopez-Estebaranz JL, Belinchón I, Riera-Monroig J, Ferrán M, Gómez-García FJ, Mateu A, Rodríguez L, Vilar-Alejo J, García-Donoso C, Ballescá F, Velasco LM, Botella-Estrada R, Herrera-Ceballos E, Ruiz-Genao DP, Descalzo MA, García-Doval I; el grupo de estudio BIOBADADERM. Nieto Benito LM, et al. Among authors: vilar alejo j. Actas Dermosifiliogr. 2022 Apr;113(4):401-406. doi: 10.1016/j.ad.2021.05.017. Epub 2021 Sep 24. Actas Dermosifiliogr. 2022. PMID: 35428502 Free article. English, Spanish.
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
Hernández-Fernández CP, Carretero G, Rivera R, Ferrándiz C, Daudén E, de Cueva P, Belinchón I, Gómez-García FJ, Herrera-Acosta E, Ruiz-Genao DP, Ferrán M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo JL, Botella-Estrada R, Sahuquillo-Torralba A, Rodríguez L, Vilar-Alejo J, García-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, López-Estebaranz JL, Pujol-Marco C, Descalzo MA, Garcia-Doval I; the BIOBADADERM Study Group. Hernández-Fernández CP, et al. Among authors: vilar alejo j. Acta Derm Venereol. 2021 Jan 4;101(1):adv00354. doi: 10.2340/00015555-3711. Acta Derm Venereol. 2021. PMID: 33269405 Free PMC article.
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
Baniandrés-Rodríguez O, Vilar-Alejo J, Rivera R, Carrascosa JM, Daudén E, Herrera-Acosta E, Sahuquillo-Torralba A, Gómez-García FJ, Nieto-Benito LM, de la Cueva P, López-Estebaranz JL, Belinchón I, Ferrán Farrés M, Alsina M, Fernández-Freire LR, Carretero G, García-Donoso C, Ballescá F, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Ruiz-Genao DP, Riera-Monroig J, Descalzo Gallego MÁ, García-Doval I; BIOBADADERM Study Group. Baniandrés-Rodríguez O, et al. Among authors: vilar alejo j. J Am Acad Dermatol. 2021 Feb;84(2):513-517. doi: 10.1016/j.jaad.2020.10.046. Epub 2020 Oct 26. J Am Acad Dermatol. 2021. PMID: 33122022 Free PMC article. No abstract available.
The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry.
Munera-Campos M, Vilar-Alejo J, Rivera R, Carrascosa JM, Daudén E, Herrera-Acosta E, Sahuquillo-Torralba A, Gómez-García FJ, Baniandrés-Rodríguez O, de la Cueva P, López-Estebaranz JL, Belinchón I, Ferran M, Riera-Monroig J, Rodriguez L, Carretero G, García-Donoso C, Ballescá F, Llamas-Velasco M, Herrera-Ceballos E, Pujol-Marco C, Nieto-Benito LM, Ruiz-Genao DP, Alsina M, Descalzo MA, García-Doval I; BIOBADADERM Study Group. Munera-Campos M, et al. Among authors: vilar alejo j. J Dermatolog Treat. 2022 Jun;33(4):2110-2117. doi: 10.1080/09546634.2021.1922572. Epub 2022 Mar 23. J Dermatolog Treat. 2022. PMID: 33913796 Free article.
Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry.
Ruiz-Genao DP, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Belinchón I, Gómez-García FJ, Herrera-Acosta E, López-Estebaranz JL, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo JL, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, García-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Descalzo MA, García-Doval I; en nombre del grupo BIOBADADERM. Ruiz-Genao DP, et al. Among authors: vilar alejo j. Actas Dermosifiliogr (Engl Ed). 2020 Nov;111(9):752-760. doi: 10.1016/j.ad.2020.05.008. Epub 2020 Oct 12. Actas Dermosifiliogr (Engl Ed). 2020. PMID: 33058793 Free article. English, Spanish.
16 results